| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |